Interview with Emmanuel Walckenaer - CEO of Yseop
Already a leading provider of Generative AI for life sciences, Yseop leverages AWS for greater scalability and the acceleration of new drug introductions
The post With Support from AWS, Yseop Develops a Unique Generative AI Application for Regulatory Document Generation Across BioPharma Appeared first on yseop.
Discover the transformative potential of Generative AI in pharmaceuticals. Dive into five essential steps for implementation and investment, from leveraging competitive advantages to ensuring compliance with industry standards. Unveil the future of Pharma innovation with Generative AI.
The post Generative AI for Pharma: 5 Steps for Implementation & Investment Appeared first on yseop.
Finalists at the 2024 Citeline Awards for the Best Use of Artificial Intelligence in Clinical Trials
The post Yseop Back-to-Back Finalists at Citeline Awards for Best Use of Artificial Intelligence in Clinical Trials Appeared first on yseop.
Emmanuel Walckenaer, CEO of Yseop, dives into how medical writers and pharma companies can get started in AI 101: Guide for Medical Writers.
The post AI 101: Guide for medical writers Appeared first on yseop.
Yseop has been honored as a finalist in the 2024 Business Intelligence Group's Artificial Intelligence Excellence Awards.
The post Yseop Shortlisted for Business Intelligence Group's Artificial Intelligence Excellence Awards Appeared first on yseop.
Tim Martin, Executive VP of Product & Development at Yseop was recently featured in Forbes discussing AI regulation and the EU AI Act.
The post The Promise & Challenge Of Deploying AI In Clinical Trials Appeared first on yseop.
Listen to the eighth episode of AI Uncovered with Fred Schonenberg
The post AI Uncovered with Fred Schonenberg (The Vital Role of GenAI in Enterprises) Appeared first on yseop.
See how Yseop Copilot is different from other Generative AI technologies across BioPharma and regulated industries.
The post Yseop Copilot vs. Alternative GenAI Technologies Appeared first on yseop.
Reinforcing Yseop's unique footprint in the GenAI space for BioPharma, a new investment enables Yseop to expand the scope of its Generative AI offerings and accelerate its leadership position in life sciences.
The post The Promise And Challenge Of Deploying AI In Clinical Trials Appeared first on yseop.
Generative AI technologies enable the pharmaceutical industry to provide enhanced and quality content automation.
The post A Recap of Pharma AI Trends in 2023 Appeared first on yseop.